Skip to main content
Sister Publication Links
  • ESG: THE NEW IMPERATIVE
Subscribe
  • My Account
  • Login
  • Subscribe
  • News
    • Current News
    • COVID-19
    • Providers
    • Insurance
    • Government
    • Finance
    • Technology
    • Safety & Quality
    • Transformation
    • People
    • Regional News
    • Digital Edition (Web Version)
    • Patients
    • Operations
    • Care Delivery
    • Payment
    • Midwest
    • Northeast
    • South
    • West
  • Digital Health
  • Insights
    • ACA 10 Years After
    • Best Practices
    • Special Reports
    • Innovations
  • Data/Lists
    • Rankings/Lists
    • Interactive Databases
    • Data Points
  • Opinion
    • Bold Moves
    • Breaking Bias
    • Commentaries
    • Letters
    • Vital Signs Blog
    • From the Editor
  • Events & Awards
    • Awards
    • Conferences
    • Galas
    • Virtual Briefings
    • Custom Media Event: ESG Summit
    • Webinars
    • Nominate/Eligibility
    • 100 Most Influential People
    • 50 Most Influential Clinical Executives
    • Best Places to Work in Healthcare
    • Excellence in Governance
    • Health Care Hall of Fame
    • Healthcare Marketing Impact Awards
    • Top 25 Emerging Leaders
    • Top 25 Innovators
    • Diversity in Healthcare
      • - Luminaries
      • - Top 25 Diversity Leaders
      • - Leaders to Watch
    • Women in Healthcare
      • - Luminaries
      • - Top 25 Women Leaders
      • - Women to Watch
    • Leadership Symposium
    • Social Determinants of Health Symposium
    • Transformation Summit
    • Women Leaders in Healthcare Conference
    • Best Places to Work Awards Gala
    • Health Care Hall of Fame Gala
    • Top 25 Diversity Leaders Gala
    • Top 25 Women Leaders Gala
    • - Hospital of the Future
    • - Value Based Care
    • - Supply Chain Revenue Cycle
    • - Hospital at Home
    • - Workplace of the Future
    • - Virtual Health
    • - Future of Healthcare Staffing
  • Multimedia
    • Podcast - Beyond the Byline
    • Sponsored Podcast - Healthcare Insider
    • Video Series - The Check Up
    • Sponsored Video Series - One on One
  • MORE +
    • Advertise
    • Media Kit
    • Newsletters
    • Jobs
    • People on the Move
    • Reprints & Licensing
MENU
Breadcrumb
  1. Home
  2. Government
February 09, 2016 12:00 AM

Senators argue over mandatory NIH funding in 21st Century Cures companion bills

Shannon Muchmore
  • Tweet
  • Share
  • Share
  • Email
  • More
    Reprints Print

    A Senate committee on Tuesday moved forward with several bills that are a part of companion legislation to the House's 21st Century Cures Act, but lawmakers disagreed about mandatory funding for federal health agencies.

    The House passed the healthcare innovation bill by a wide margin in July. It includes more than $8 billion in mandatory funding for the National Institutes of Health. The Senate has struggled with companion legislation mostly because there isn't a plan for how to pay for the bill.

    Sen. Lamar Alexander (R-Tenn.), chairman of the Senate Health, Education, Labor and Pensions Committee, last month said his panel would take a piecemeal approach by marking up batches of smaller bills in the coming months. The first hearing of seven bills was Tuesday and all were approved. They range from expediting therapies for rare diseases to improving electronic health records.

    The committee will have markups on the rest of the bills that were formerly part of the Senate version of 21st Century Cures in March and April and then take them to the floor. The legislation would also likely support President Barack Obama's precision medicine initiative as well as his more recently announced project to research cancer treatment, Alexander said.

    Most of the argument during the hearing Tuesday revolved around whether mandatory NIH funding should be included in any innovation bill.

    Sen. Elizabeth Warren (D-Mass.) said the NIH will fall dangerously behind in research without mandatory funding. The need for biomedical innovation is urgent, but she worries that Republicans will use legislation to “neuter the FDA” instead of strengthen it, she said.

    The issue should be addressed in committee and not postponed until floor discussion, Warren said. A recent boost to NIH funding in the omnibus budget agreement is not enough to make up for years of declining investment, she said.

    “Real innovation starts with basic research,” Warren said.

    Sen. Richard Burr (R-N.C.) said he agreed on mandatory funding but was not confident that enough of the committee would approve.

    “There's not going to be an innovation bill,” he said. “I plan to write one, but I don't think it's going to make it out of this committee.”

    Sen. Bill Cassidy (R-La.) said he would not support mandatory funding unless the NIH was also forced to restructure its budget as the Institute of Medicine recommended more than 20 years ago.

    Alexander acknowledged that the issue is controversial but tried to keep it from derailing potential progress.

    “There's no reason for that to stop our advance step by step,” he said.

    The bills approved by committee Tuesday include the Advanced Targeting Therapies for Rare Diseases Act of 2015, which would allow companies creating specific therapies for serious genetic diseases to more quickly develop treatments for patients who have the same disease but with a different genetic mutation. It would give the Food and Drug Administration the authority to allow the companies to use their own data for the approval process.

    Another bill that passed committee was the FDA Device Accountability Act of 2015, which gives the FDA more direction on imposing the least burdensome requirements for evaluating devices. It also allows devices to be approved by a non-local institutional review board.

    Letter
    to the
    Editor

    Send us a letter

    Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.

    Recommended for You
    medicare and money
    Inspector General pushes CMS to recover $226M in Medicare overpayments
    Ezike 800.jpg
    Former Illinois health chief Ezike under scrutiny by state's top ethics investigator
    Sponsored Content
    Modern Healthcare Alert: Sign up for this breaking news email to be kept in the loop as urgent healthcare business news unfolds.
    Get Newsletters

    Sign up for enewsletters and alerts to receive breaking news and in-depth coverage of healthcare events and trends, as they happen, right to your inbox.

    Subscribe Today
    MH Magazine Cover

    MH magazine offers content that sheds light on healthcare leaders’ complex choices and touch points—from strategy, governance, leadership development and finance to operations, clinical care, and marketing.

    Subscribe
    Connect with Us
    • LinkedIn
    • Twitter
    • Facebook
    • RSS

    Our Mission

    Modern Healthcare empowers industry leaders to succeed by providing unbiased reporting of the news, insights, analysis and data.

    Contact Us

    (877) 812-1581

    Email us

     

    Resources
    • Contact Us
    • Advertise with Us
    • Ad Choices Ad Choices
    • Sitemap
    Editorial Dept
    • Submission Guidelines
    • Code of Ethics
    • Awards
    • About Us
    Legal
    • Terms and Conditions
    • Privacy Policy
    • Privacy Request
    Modern Healthcare
    Copyright © 1996-2022. Crain Communications, Inc. All Rights Reserved.
    • News
      • Current News
      • COVID-19
      • Providers
      • Insurance
      • Government
      • Finance
      • Technology
      • Safety & Quality
      • Transformation
        • Patients
        • Operations
        • Care Delivery
        • Payment
      • People
      • Regional News
        • Midwest
        • Northeast
        • South
        • West
      • Digital Edition (Web Version)
    • Digital Health
    • Insights
      • ACA 10 Years After
      • Best Practices
      • Special Reports
      • Innovations
    • Data/Lists
      • Rankings/Lists
      • Interactive Databases
      • Data Points
    • Opinion
      • Bold Moves
      • Breaking Bias
      • Commentaries
      • Letters
      • Vital Signs Blog
      • From the Editor
    • Events & Awards
      • Awards
        • Nominate/Eligibility
        • 100 Most Influential People
        • 50 Most Influential Clinical Executives
        • Best Places to Work in Healthcare
        • Excellence in Governance
        • Health Care Hall of Fame
        • Healthcare Marketing Impact Awards
        • Top 25 Emerging Leaders
        • Top 25 Innovators
        • Diversity in Healthcare
          • - Luminaries
          • - Top 25 Diversity Leaders
          • - Leaders to Watch
        • Women in Healthcare
          • - Luminaries
          • - Top 25 Women Leaders
          • - Women to Watch
      • Conferences
        • Leadership Symposium
        • Social Determinants of Health Symposium
        • Transformation Summit
        • Women Leaders in Healthcare Conference
      • Galas
        • Best Places to Work Awards Gala
        • Health Care Hall of Fame Gala
        • Top 25 Diversity Leaders Gala
        • Top 25 Women Leaders Gala
      • Virtual Briefings
        • - Hospital of the Future
        • - Value Based Care
        • - Supply Chain Revenue Cycle
        • - Hospital at Home
        • - Workplace of the Future
        • - Virtual Health
        • - Future of Healthcare Staffing
      • Custom Media Event: ESG Summit
      • Webinars
    • Multimedia
      • Podcast - Beyond the Byline
      • Sponsored Podcast - Healthcare Insider
      • Video Series - The Check Up
      • Sponsored Video Series - One on One
    • MORE +
      • Advertise
      • Media Kit
      • Newsletters
      • Jobs
      • People on the Move
      • Reprints & Licensing